Meanwhile, there has been a proliferation of tau PET tracers with roughly similar binding properties and sensitivity for the detection of tau pathologies, with little agreement as to the optimal agent for the specific task of AD diagnosis and progression monitoring. Here, MAPT is linked to Alzheimer disease.